KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $42 | -63.2% | 23,069 | -21.6% | 0.00% | – |
Q1 2023 | $114 | +1040.0% | 29,434 | +875.6% | 0.00% | – |
Q4 2022 | $10 | -100.0% | 3,017 | -83.1% | 0.00% | – |
Q3 2022 | $97,000 | +592.9% | 17,855 | +491.8% | 0.00% | – |
Q2 2022 | $14,000 | -41.7% | 3,017 | 0.0% | 0.00% | – |
Q1 2022 | $24,000 | +26.3% | 3,017 | 0.0% | 0.00% | – |
Q4 2021 | $19,000 | +5.6% | 3,017 | 0.0% | 0.00% | – |
Q3 2021 | $18,000 | -41.9% | 3,017 | 0.0% | 0.00% | – |
Q2 2021 | $31,000 | -3.1% | 3,017 | 0.0% | 0.00% | – |
Q1 2021 | $32,000 | -31.9% | 3,017 | 0.0% | 0.00% | – |
Q4 2020 | $47,000 | +6.8% | 3,017 | 0.0% | 0.00% | – |
Q3 2020 | $44,000 | -22.8% | 3,017 | 0.0% | 0.00% | – |
Q2 2020 | $57,000 | -1.7% | 3,017 | 0.0% | 0.00% | – |
Q1 2020 | $58,000 | +1.8% | 3,017 | 0.0% | 0.00% | – |
Q4 2019 | $57,000 | +67.6% | 3,017 | -46.9% | 0.00% | – |
Q2 2019 | $34,000 | +3.0% | 5,686 | 0.0% | 0.00% | – |
Q1 2019 | $33,000 | -35.3% | 5,686 | 0.0% | 0.00% | – |
Q4 2018 | $51,000 | -47.4% | 5,686 | 0.0% | 0.00% | – |
Q3 2018 | $97,000 | 0.0% | 5,686 | 0.0% | 0.00% | – |
Q2 2018 | $97,000 | +340.9% | 5,686 | +242.9% | 0.00% | – |
Q1 2018 | $22,000 | +37.5% | 1,658 | 0.0% | 0.00% | – |
Q4 2017 | $16,000 | -11.1% | 1,658 | 0.0% | 0.00% | – |
Q3 2017 | $18,000 | +20.0% | 1,658 | 0.0% | 0.00% | – |
Q2 2017 | $15,000 | -28.6% | 1,658 | 0.0% | 0.00% | – |
Q1 2017 | $21,000 | +31.2% | 1,658 | 0.0% | 0.00% | – |
Q4 2016 | $16,000 | -50.0% | 1,658 | -50.0% | 0.00% | – |
Q3 2016 | $32,000 | +190.9% | 3,316 | +100.0% | 0.00% | – |
Q2 2016 | $11,000 | -26.7% | 1,658 | 0.0% | 0.00% | – |
Q1 2016 | $15,000 | -31.8% | 1,658 | 0.0% | 0.00% | – |
Q4 2015 | $22,000 | +22.2% | 1,658 | 0.0% | 0.00% | – |
Q3 2015 | $18,000 | -60.0% | 1,658 | 0.0% | 0.00% | – |
Q2 2015 | $45,000 | -11.8% | 1,658 | 0.0% | 0.00% | – |
Q1 2015 | $51,000 | -17.7% | 1,658 | 0.0% | 0.00% | – |
Q4 2014 | $62,000 | – | 1,658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |